Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 27 February, 2024|Author: Getaka | Social: X Twitter Profile

Fundamental Analysis of Krebs Biochemicals & Industries Ltd

About the Company - Krebs Biochemicals & Industries Ltd

Krebs Biochemicals & Industries Ltd. is a Public Limited Listed company incorporated on 02/12/1991 and has its registered office in the State of Andhra Pradesh, India. Company’s Corporate Identification Number(CIN) is L24110AP1991PLC103912 and registration number is 103912. Currently company belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 59.70 Cr. and Equity Capital is Rs. 21.56 Cr. for the Year ended 31/03/2022.
INDUSTRYADDRESSCONTACT
PharmaceuticalsKothapalli Village, Anakapalli Dist. Andhra Pradesh 531031investors@krebsbiochem.com
http://www.krebsbiochem.com
Management
NamePosition Held
Dr. R T RaviChairman & Non-Exe.Director
Mr. Jitendra ShahManaging Director & CEO
Mr. Pabitrakumar Kalipada BhattacharyyaNon Executive Director
Mr. Avinash RaviNon Executive Director
Mr. G V L PrasadIndependent Director
Mr. Raj Kamal Prasad VermaIndependent Director
Dr. Tangirala MalatiIndependent Director
Mr. Satish KhivsaraIndependent Director

Krebs Biochemicals & Industries Ltd. Share Price Update

Share PriceValue
Today₹73.40
Previous Day₹73.40

Basic Stock Data of Krebs Biochemicals & Industries Ltd

Market Cap 156 Cr.
Current Price 72.4
High / Low94.0/50.6
Stock P/E
Book Value 50.3
Dividend Yield0.00 %
ROCE28.6 %
ROE%
Face Value 10.0

Data Source: screener.in

Competitors of Krebs Biochemicals & Industries Ltd

Stock NameMarket CapCurrent PriceHigh / LowStock P/EBook ValueDividend YieldROCEROEFace Value
Procter & Gamble Health Ltd 8,416 Cr. 5,0705,643/4,48837.1 4851.88 %45.5 %33.5 % 10.0
Sequent Scientific Ltd 3,483 Cr. 140156/61.8 25.30.00 %3.43 %8.98 % 2.00
Syncom Formulations (India) Ltd 1,391 Cr. 14.818.6/4.5554.9 2.870.00 %9.70 %8.42 % 1.00
Venus Remedies Ltd 456 Cr. 341430/15115.7 3520.00 %7.75 %5.90 % 10.0
Vivimed Labs Ltd 41.0 Cr. 4.957.76/4.85 21.30.00 %51.5 %163 % 2.00
Industry Average2,757.40 Cr1,114.1521.54177.290.38%23.58%43.96%5.00

Krebs Biochemicals & Industries Ltd Quarterly Results

MonthSep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
Sales16.699.5815.866.7611.9821.8119.1610.6420.949.0911.4610.5814.89
Expenses19.7915.2320.3813.2919.7631.7128.9416.9122.8412.0716.0813.2015.79
Operating Profit-3.10-5.65-4.52-6.53-7.78-9.90-9.78-6.27-1.90-2.98-4.62-2.62-0.90
OPM %-18.57%-58.98%-28.50%-96.60%-64.94%-45.39%-51.04%-58.93%-9.07%-32.78%-40.31%-24.76%-6.04%
Other Income0.070.060.440.030.130.200.790.130.270.020.190.040.17
Interest2.121.431.491.511.781.820.280.300.740.901.031.101.13
Depreciation1.241.241.411.421.421.422.051.691.691.691.481.651.71
Profit before tax-6.39-8.26-6.98-9.43-10.85-12.94-11.32-8.13-4.06-5.55-6.94-5.33-3.57
Tax %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Net Profit-6.39-8.26-6.99-9.42-10.85-12.94-11.31-8.14-4.06-5.55-6.94-5.33-3.57
EPS in Rs-3.26-4.21-3.56-4.37-5.03-6.00-5.25-3.78-1.88-2.57-3.22-2.47-1.66

Krebs Biochemicals & Industries Ltd Quarterly Chart

Krebs Biochemicals & Industries Ltd Profit & Loss

MonthMar 2012Jun 2013Sep 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023TTM
Sales6911001334483354605250
Expenses732445141141585271946860
Operating Profit-4-13-4-5-12-8-8-10-19-18-34-16-10
OPM %-5%-117%-1,088%-248%-22%-20%-56%-33%-57%-30%-20%
Other Income36031-0-1001110
Interest9104135666534
Depreciation10802444455677
Profit before tax-19-16-4-8-16-16-18-20-29-28-45-25-21
Tax %10%5%-10%0%0%0%0%0%0%0%0%0%
Net Profit-17-15-4-8-16-16-18-20-29-28-45-25-21
EPS in Rs-15.17-13.22-3.78-6.82-10.33-9.67-10.73-12.03-16.04-14.45-20.65-11.45-9.66
Dividend Payout %0%0%0%0%0%0%0%0%0%0%0%0%

Krebs Biochemicals & Industries Ltd Profit & Loss Yearly Chart

Krebs Biochemicals & Industries Ltd Growth

Compounded Sales Growth
10 Years:%
5 Years:9%
3 Years:16%
TTM:-17%
Compounded Profit Growth
10 Years:%
5 Years:-12%
3 Years:5%
TTM:28%
Stock Price CAGR
10 Years:16%
5 Years:-4%
3 Years:-14%
1 Year:-3%
Return on Equity
10 Years:%
5 Years:%
3 Years:%
Last Year:%

Krebs Biochemicals & Industries Ltd Balance Sheet

MonthMar 2012Jun 2013Sep 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Sep 2023
Equity Capital10101010131414171820222222
Reserves14-2-65-4-12-32-31-43-67-97-121-130
Preference Capital000000003030130130
Borrowings869393613148565336811353188
Other Liabilities3937413377738710312312525222199
Total Liabilities149138138108116122126142134159190175178
Fixed Assets6551585893102101101105118139147154
CWIP070011443412840
Investments0000000000000
Other Assets83808050131621382429432424
Total Assets149138138108116122126142134159190175178

Krebs Biochemicals & Industries Ltd Reserves and Borrowings Chart

Krebs Biochemicals & Industries Ltd Cash Flow

MonthMar 2012Jun 2013Sep 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Cash from Operating Activity 7-249-45-15-11-64-36-15-17-25
Cash from Investing Activity -160-3-4-5-3-4-10-23-23-13
Cash from Financing Activity -6-4-4954131691729384037
Net Cash Flow0-006-6-0017-171-1-0

Krebs Biochemicals & Industries Ltd Financial Efficiency Indicators

MonthMar 2012Jun 2013Sep 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Debtor Days4130101803222254
Inventory Days2862,36814,7042,162337142345234230170
Days Payable2561,51732,2504,360510339521292340217
Cash Conversion Cycle70881-17,536-2,018-170-175-174-57-106-44
Working Capital Days-6-446-6,532-2,132-275-315-267-119-200-162
ROCE %-9%-15%-4%-8%-27%-27%-26%-36%-57%-42%-59%-29%

Krebs Biochemicals & Industries Ltd Financial Efficiency Indicators Chart

Krebs Biochemicals & Industries Ltd Share Holding Pattern

MonthMar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
Promoters70.05%72.74%72.74%72.74%72.74%72.74%72.74%72.72%72.74%72.74%72.74%72.74%
FIIs0.01%0.01%0.01%0.01%0.01%0.01%0.01%0.33%0.50%0.50%0.50%0.50%
Public29.94%27.25%27.25%27.25%27.25%27.25%27.26%26.95%26.76%26.77%26.76%26.77%
No. of Shareholders6,4007,0968,5718,1669,5319,5339,6509,2949,3159,3939,0308,990

Krebs Biochemicals & Industries Ltd Shareholding Pattern Chart

No. of Krebs Biochemicals & Industries Ltd Shareholders

This stock is not held by any mutual fund

Krebs Biochemicals & Industries Ltd ROCE Trend

Krebs Biochemicals & Industries Ltd EPS Trend

Krebs Biochemicals & Industries Ltd Key Financial Ratios

MonthMar 23Mar 22Mar 21Mar 20Mar 19
FaceValue10.0010.0010.0010.0010.00
Basic EPS (Rs.)-11.30-20.81-14.53-16.75-12.83
Diluted EPS (Rs.)-11.30-20.81-14.53-17.90-15.46
Cash EPS (Rs.)-8.41-17.73-11.84-13.44-9.38
Book Value[Excl.RevalReserv]/Share (Rs.)-46.13-34.83-21.78-13.89-8.59
Book Value[Incl.RevalReserv]/Share (Rs.)-46.13-34.83-21.78-13.89-8.59
Revenue From Operations / Share (Rs.)24.1827.6927.3718.5628.72
PBDIT / Share (Rs.)-7.03-15.23-8.64-10.15-5.70
PBIT / Share (Rs.)-10.07-18.15-11.25-12.75-8.35
PBT / Share (Rs.)-11.45-20.65-14.45-16.04-12.03
Net Profit / Share (Rs.)-11.45-20.65-14.45-16.04-12.03
PBDIT Margin (%)-29.07-55.00-31.57-54.66-19.85
PBIT Margin (%)-41.65-65.55-41.11-68.67-29.07
PBT Margin (%)-47.36-74.58-52.80-86.41-41.90
Net Profit Margin (%)-47.36-74.58-52.80-86.41-41.90
Return on Capital Employeed (%)-17.25-35.02-19.88-25.30-15.86
Return On Assets (%)-14.11-23.45-17.81-21.57-14.05
Long Term Debt / Equity (X)-1.74-1.77-2.35-2.62-3.52
Total Debt / Equity (X)-1.84-1.90-2.35-2.62-3.52
Asset Turnover Ratio (%)0.280.340.360.240.35
Current Ratio (X)0.320.450.440.430.56
Quick Ratio (X)0.080.120.090.080.40
Inventory Turnover Ratio (X)0.812.191.621.602.03
Interest Coverage Ratio (X)-5.10-6.09-2.70-3.08-1.52
Interest Coverage Ratio (Post Tax) (X)-7.30-7.26-3.52-3.87-2.23
Enterprise Value (Cr.)304.75451.99274.16212.76225.82
EV / Net Operating Revenue (X)5.857.575.116.374.73
EV / EBITDA (X)-20.10-13.76-16.17-11.65-23.82
MarketCap / Net Operating Revenue (X)2.335.183.254.414.04
Price / BV (X)-1.22-4.12-4.08-5.90-13.50
Price / Net Operating Revenue (X)2.335.183.254.414.04
EarningsYield-0.20-0.14-0.16-0.19-0.10

Krebs Biochemicals & Industries Ltd Profitability Ratios (%)

Krebs Biochemicals & Industries Ltd Liquidity Ratios

Krebs Biochemicals & Industries Ltd Liquidity Ratios (%)

Krebs Biochemicals & Industries Ltd Interest Coverage Ratios (%)

Krebs Biochemicals & Industries Ltd Valuation Ratios

Fair Value of Krebs Biochemicals & Industries Ltd Stock

Fair Value: ₹115.44

The stock is undervalued by 59.45% compared to the current price ₹72.4

*Investments are subject to market risks

Strength and Weakness of Krebs Biochemicals & Industries Ltd Stock

StrengthWeakness
  1. The stock has a low average Working Capital Days of -149.83, which is a positive sign.
  1. The stock is trading at a high valuation with an average P/B ratio of -12.11 and average Dividend Yield of -60.61%.
  2. The stock has a low average ROCE of -28.25%, which may not be favorable.
  3. The stock has a high average Cash Conversion Cycle of 17.17, which may not be favorable.
  4. The company has higher borrowings (24.62) compared to reserves (-40.46), which may suggest financial risk.
  5. The company has not shown consistent growth in sales (31.92) and profit (-20.38).

About the Author

Author Avatar
Getaka

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Krebs Biochemicals & Industries Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE